Chang Y - Search Results

1

Pulmonary sequestration presenting with left upper abdominal bloating and marked elevation of serum carbohydrate antigen 19-9: A case report.

Han P, Luo Y, Tian D, Yan W, Liu J, Chang Y, Xie H, Wei W, Huang H. Han P, et al. Among authors: chang y. Oncol Lett. 2014 May;7(5):1493-1496. doi: 10.3892/ol.2014.1960. Epub 2014 Mar 11. Oncol Lett. 2014. PMID: 24765162 Free PMC article.

2

Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.

He XX, Guo AY, Xu CR, Chang Y, Xiang GY, Gong J, Dan ZL, Tian DA, Liao JZ, Lin JS. He XX, et al. Among authors: chang y. Oncol Rep. 2014 Sep;32(3):1200-10. doi: 10.3892/or.2014.3306. Epub 2014 Jul 3. Oncol Rep. 2014. PMID: 24993451

3

The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.

He XX, Kuang SZ, Liao JZ, Xu CR, Chang Y, Wu YL, Gong J, Tian DA, Guo AY, Lin JS. He XX, et al. Among authors: chang y. Mol Biosyst. 2015 Feb;11(2):532-9. doi: 10.1039/c4mb00563e. Epub 2014 Nov 26. Mol Biosyst. 2015. PMID: 25424171

4

miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.

Yan JJ, Chang Y, Zhang YN, Lin JS, He XX, Huang HJ. Yan JJ, et al. Among authors: chang y. Oncol Lett. 2017 May;13(5):3118-3126. doi: 10.3892/ol.2017.5826. Epub 2017 Mar 8. Oncol Lett. 2017. PMID: 28529562 Free PMC article.

5

Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1).

Li P, Du Q, Cao Z, Guo Z, Evankovich J, Yan W, Chang Y, Shao L, Stolz DB, Tsung A, Geller DA. Li P, et al. Among authors: chang y. Cancer Lett. 2012 Jan 28;314(2):213-22. doi: 10.1016/j.canlet.2011.09.031. Epub 2011 Oct 1. Cancer Lett. 2012. PMID: 22056812 Free PMC article.

6

Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand.

Zhang S, Xia C, Xu C, Liu J, Zhu H, Yang Y, Xu F, Zhao J, Chang Y, Zhao Q. Zhang S, et al. Among authors: chang y. Int J Oncol. 2017 Mar;50(3):805-814. doi: 10.3892/ijo.2017.3855. Epub 2017 Jan 18. Int J Oncol. 2017. PMID: 28098878

7

Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.

Cai X, Zhou J, Chang Y, Sun X, Li P, Lin J. Cai X, et al. Among authors: chang y. Cancer Lett. 2008 Jun 8;264(1):71-82. doi: 10.1016/j.canlet.2008.01.027. Epub 2008 Apr 14. Cancer Lett. 2008. PMID: 18407409

8

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT, Tsung A. Yan W, et al. Among authors: chang y. Hepatology. 2012 Jun;55(6):1863-75. doi: 10.1002/hep.25572. Hepatology. 2012. PMID: 22234969 Free PMC article.

9

Splenocyte apoptosis and autophagy is mediated by interferon regulatory factor 1 during murine endotoxemia.

Zhang L, Cardinal JS, Pan P, Rosborough BR, Chang Y, Yan W, Huang H, Billiar TR, Rosengart MR, Tsung A. Zhang L, et al. Among authors: chang y. Shock. 2012 May;37(5):511-7. doi: 10.1097/SHK.0b013e318249cfa2. Shock. 2012. PMID: 22266972 Free PMC article.

10

miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.

Chang Y, Yan W, He X, Zhang L, Li C, Huang H, Nace G, Geller DA, Lin J, Tsung A. Chang Y, et al. Gastroenterology. 2012 Jul;143(1):177-87.e8. doi: 10.1053/j.gastro.2012.04.009. Epub 2012 Apr 12. Gastroenterology. 2012. PMID: 22504094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,552 results

Search Page

Filters